Adrenal Vein Sampling Lateralization Despite Mineralocorticoid Receptor Antagonists Exposure in Primary Aldosteronism
- PMID: 30239792
- PMCID: PMC6316984
- DOI: 10.1210/jc.2018-01299
Adrenal Vein Sampling Lateralization Despite Mineralocorticoid Receptor Antagonists Exposure in Primary Aldosteronism
Abstract
Context: Many antihypertensive medications modulate the renin-angiotensin-aldosterone system, possibly skewing the diagnosis and subtyping of primary aldosteronism (PA). Particularly, mineralocorticoid receptor antagonists (MRA) might raise renin and stimulate aldosterone synthesis from nonautonomous areas, potentially obscuring lateralization on adrenal vein sampling (AVS). Withdrawal of MRA in severe PA, however, can precipitate hypokalemia and/or hypertension and therefore is not always practical.
Objective: To assess the effects of MRA on the interpretation of AVS data.
Design and participants: A cohort study of all PA patients who underwent AVS at University of Michigan between January 2009 and January 2018 was conducted. Demographics, diagnostic, AVS, surgical pathology, and follow-up data were collected retrospectively.
Results: Of 191 patients who underwent AVS, 51 (27%) were exposed to MRA at the time of the procedure. Plasma aldosterone concentration and the daily defined dose of antihypertensives were higher in patients taking vs those not taking MRA. Unilateral PA was more frequent in the MRA group, both precosyntropin and postcosyntropin (P < 0.05). The MRA group included two patients with unsuppressed renin, who demonstrated unequivocal AVS lateralization. To date, 86 patients underwent unilateral adrenalectomy, including 30 patients taking MRA during AVS. The proportion of clinical and biochemical success was not statistically different between patients exposed to and those not exposed to MRA during AVS (P = 0.17 and 0.65, respectively).
Conclusion: Our data suggest that conclusive AVS lateralization is often achieved in patients with severe PA despite MRA use.
Figures
Similar articles
-
Evaluation of Adrenal Vein Sampling Use and Outcomes in Patients With Primary Aldosteronism.J Surg Res. 2020 Dec;256:673-679. doi: 10.1016/j.jss.2020.05.099. Epub 2020 Aug 19. J Surg Res. 2020. PMID: 32827833
-
Outcome of adrenal vein sampling performed during concurrent mineralocorticoid receptor antagonist therapy.J Clin Endocrinol Metab. 2014 Dec;99(12):4397-402. doi: 10.1210/jc.2014-2788. J Clin Endocrinol Metab. 2014. PMID: 25222758
-
Adrenal Vein Sampling Without Discontinuation of Mineralocorticoid Receptor Antagonist Therapy.Endocr Pract. 2020 Sep;26(9):953-959. doi: 10.4158/EP-2019-0599. Endocr Pract. 2020. PMID: 33471699
-
Systematic review: diagnostic procedures to differentiate unilateral from bilateral adrenal abnormality in primary aldosteronism.Ann Intern Med. 2009 Sep 1;151(5):329-37. doi: 10.7326/0003-4819-151-5-200909010-00007. Ann Intern Med. 2009. PMID: 19721021 Review.
-
New concepts in adrenal vein sampling for aldosterone in the diagnosis of primary aldosteronism.Curr Hypertens Rep. 2007 Apr;9(2):90-7. doi: 10.1007/s11906-007-0017-3. Curr Hypertens Rep. 2007. PMID: 17442218 Review.
Cited by
-
Efficacy of Oral Furosemide Test for Primary Aldosteronism Diagnosis.J Endocr Soc. 2023 Nov 24;8(1):bvad147. doi: 10.1210/jendso/bvad147. eCollection 2023 Dec 1. J Endocr Soc. 2023. PMID: 38075562 Free PMC article.
-
Diagnosis and management of primary hyperaldosteronism in patients with hypertension: a practical approach endorsed by the British and Irish Hypertension Society.J Hum Hypertens. 2024 Jan;38(1):8-18. doi: 10.1038/s41371-023-00875-1. Epub 2023 Nov 14. J Hum Hypertens. 2024. PMID: 37964158 Free PMC article. Review.
-
2023 Korean Endocrine Society Consensus Guidelines for the Diagnosis and Management of Primary Aldosteronism.Endocrinol Metab (Seoul). 2023 Dec;38(6):597-618. doi: 10.3803/EnM.2023.1789. Epub 2023 Oct 13. Endocrinol Metab (Seoul). 2023. PMID: 37828708 Free PMC article.
-
Biomarkers to Guide Medical Therapy in Primary Aldosteronism.Endocr Rev. 2024 Jan 4;45(1):69-94. doi: 10.1210/endrev/bnad024. Endocr Rev. 2024. PMID: 37439256 Review.
-
Imaging or Adrenal Vein Sampling Approach in Primary Aldosteronism? A Patient-Based Approach.Tomography. 2022 Nov 9;8(6):2735-2748. doi: 10.3390/tomography8060228. Tomography. 2022. PMID: 36412687 Free PMC article. Review.
References
-
- Rossi GP, Bernini G, Caliumi C, Desideri G, Fabris B, Ferri C, Ganzaroli C, Giacchetti G, Letizia C, Maccario M, Mallamaci F, Mannelli M, Mattarello MJ, Moretti A, Palumbo G, Parenti G, Porteri E, Semplicini A, Rizzoni D, Rossi E, Boscaro M, Pessina AC, Mantero F; PAPY Study Investigators . A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients. J Am Coll Cardiol. 2006;48(11):2293–2300. - PubMed
-
- Douma S, Petidis K, Doumas M, Papaefthimiou P, Triantafyllou A, Kartali N, Papadopoulos N, Vogiatzis K, Zamboulis C. Prevalence of primary hyperaldosteronism in resistant hypertension: a retrospective observational study. Lancet. 2008;371(9628):1921–1926. - PubMed
-
- Catena C, Colussi G, Lapenna R, Nadalini E, Chiuch A, Gianfagna P, Sechi LA. Long-term cardiac effects of adrenalectomy or mineralocorticoid antagonists in patients with primary aldosteronism. Hypertension. 2007;50(5):911–918. - PubMed
-
- Fourkiotis V, Vonend O, Diederich S, Fischer E, Lang K, Endres S, Beuschlein F, Willenberg HS, Rump LC, Allolio B, Reincke M, Quinkler M; Mephisto Study Group . Effectiveness of eplerenone or spironolactone treatment in preserving renal function in primary aldosteronism. Eur J Endocrinol. 2012;168(1):75–81. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
